Putnam Investments’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-42,238
| Closed | -$2.93M | – | 1182 |
|
|
2023
Q3 | $2.93M | Buy |
42,238
+3,373
| +9% | +$271K | ﹤0.01% | 618 |
|
|
2023
Q2 | $3.67M | Sell |
38,865
-2,823
| -7% | -$245K | 0.01% | 540 |
|
|
2023
Q1 | $3.45M | Sell |
41,688
-41,594
| -50% | -$3.27M | 0.01% | 547 |
|
|
2022
Q4 | $6.21M | Sell |
83,282
-54,841
| -40% | -$4.23M | 0.01% | 392 |
|
|
2022
Q3 | $11.4M | Sell |
138,123
-142,665
| -51% | -$13.7M | 0.02% | 266 |
|
|
2022
Q2 | $26.7M | Sell |
280,788
-215,640
| -43% | -$22.3M | 0.05% | 179 |
|
|
2022
Q1 | $58.4M | Sell |
496,428
-320,897
| -39% | -$36M | 0.09% | 146 |
|
|
2021
Q4 | $106M | Sell |
817,325
-118,769
| -13% | -$13.9M | 0.15% | 125 |
|
|
2021
Q3 | $106M | Sell |
936,094
-13,675
| -1% | -$1.56M | 0.16% | 128 |
|
|
2021
Q2 | $98.4M | Sell |
949,769
-42,704
| -4% | -$4.03M | 0.15% | 133 |
|
|
2021
Q1 | $83M | Buy |
992,473
+301,561
| +44% | +$25.5M | 0.14% | 138 |
|
|
2020
Q4 | $63M | Buy |
690,912
+219,501
| +47% | +$18.2M | 0.11% | 151 |
|
|
2020
Q3 | $37.6M | Buy |
471,411
+93,448
| +25% | +$7.29M | 0.07% | 177 |
|
|
2020
Q2 | $26.1M | Sell |
377,963
-1,520,482
| -80% | -$108M | 0.06% | 198 |
|
|
2020
Q1 | $119M | Sell |
1,898,445
-159,846
| -8% | -$11.5M | 0.31% | 88 |
|
|
2019
Q4 | $160M | Buy |
2,058,291
+1,321,332
| +179% | +$103M | 0.33% | 88 |
|
|
2019
Q3 | $54M | Buy |
736,959
+397,911
| +117% | +$28M | 0.12% | 158 |
|
|
2019
Q2 | $20.9M | Sell |
339,048
-58,944
| -15% | -$3.56M | 0.05% | 241 |
|
|
2019
Q1 | $25.4M | Buy |
397,992
+205,851
| +107% | +$11.7M | 0.06% | 221 |
|
|
2018
Q4 | $9.81M | Buy |
192,141
+86,445
| +82% | +$4.37M | 0.03% | 325 |
|
|
2018
Q3 | $6.13M | Sell |
105,696
-99,741
| -49% | -$4.88M | 0.01% | 512 |
|
|
2018
Q2 | $9.97M | Buy |
205,437
+14,169
| +7% | +$661K | 0.02% | 373 |
|
|
2018
Q1 | $8.89M | Buy |
191,268
+181,500
| +1,858% | +$7.88M | 0.02% | 391 |
|
|
2017
Q4 | $367K | Sell |
9,768
-1,638
| -14% | -$60.1K | ﹤0.01% | 993 |
|
|
2017
Q3 | $416K | Sell |
11,406
-1,080
| -9% | -$41.2K | ﹤0.01% | 1008 |
|
|
2017
Q2 | $492K | Sell |
12,486
-645
| -5% | -$23.5K | ﹤0.01% | 979 |
|
|
2017
Q1 | $412K | Sell |
13,131
-181,893
| -93% | -$5.69M | ﹤0.01% | 1132 |
|
|
2016
Q4 | $6.09M | Sell |
195,024
-519,006
| -73% | -$16.8M | 0.01% | 512 |
|
|
2016
Q3 | $28.7M | Sell |
714,030
-114,432
| -14% | -$4.31M | 0.07% | 232 |
|
|
2016
Q2 | $27.5M | Sell |
828,462
-18,222
| -2% | -$623K | 0.07% | 244 |
|
|
2016
Q1 | $24.9M | Sell |
846,684
-1,659,480
| -66% | -$45.8M | 0.06% | 258 |
|
|
2015
Q4 | $66M | Buy |
2,506,164
+535,554
| +27% | +$13.9M | 0.15% | 147 |
|
|
2015
Q3 | $46.7M | Buy |
1,970,610
+644,754
| +49% | +$15.6M | 0.1% | 194 |
|
|
2015
Q2 | $31.5M | Buy |
1,325,856
+9,246
| +0.7% | +$209K | 0.06% | 264 |
|
|
2015
Q1 | $31.3M | Buy |
1,316,610
+491,946
| +60% | +$11M | 0.06% | 266 |
|
|
2014
Q4 | $17.5M | Buy |
824,664
+770,958
| +1,436% | +$15.5M | 0.04% | 365 |
|
|
2014
Q3 | $914K | Buy |
53,706
+27,306
| +103% | +$431K | ﹤0.01% | 1225 |
|
|
2014
Q2 | $378K | Hold |
26,400
| – | – | ﹤0.01% | 1372 |
|
|
2014
Q1 | $326K | Sell |
26,400
-600
| -2% | -$6.92K | ﹤0.01% | 1422 |
|
|
2013
Q4 | $296K | Sell |
27,000
-72
| -0.3% | -$812 | ﹤0.01% | 1424 |
|
|
2013
Q3 | $314K | Buy |
27,072
+672
| +3% | +$7.86K | ﹤0.01% | 1408 |
|
|
2013
Q2 | $296K | Buy |
+26,400
| New | +$312K | ﹤0.01% | 1397 |
|
Other funds holding EW
Putnam Investments's EW Position: Q4 2023 in Review
Putnam Investments sold out of Edwards Lifesciences (EW) in Q4 2023, closing a stake of 42,238 shares — an estimated $2.93M sold.
Putnam Investments first reported a position in EW in Q2 2013 and held it in 42 quarters. The position peaked at $160M in Q4 2019. 1,244 funds tracked by Wall St. Rank hold EW as of Q4 2023.
- Putnam Investments reported no remaining Edwards Lifesciences position as of Q4 2023 after selling out during the quarter.
- Putnam Investments sold 42,238 Edwards Lifesciences shares in Q4 2023, an estimated $2.93M.
- Putnam Investments first reported a position in Edwards Lifesciences in Q2 2013 and held it in 42 quarters.
- Putnam Investments's Edwards Lifesciences position peaked at $160M in Q4 2019.
- 1,244 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2023.
Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.